Reno-and hepato-protective effect of allopurinol after renal ischemia/reperfusion injury: Crosstalk between xanthine oxidase and peroxisome proliferator-activated …

E Soliman, SM Elshazly, SM Shewaikh… - Food and Chemical …, 2023 - Elsevier
Renal ischemia/reperfusion (I/R) is a common cause of acute kidney injury and remote liver
damage is an ultimate negative outcome. Current treatments for renal I/R typically involve …

[HTML][HTML] Xanthohumol protects against renal ischaemia reperfusion (I/R) injury by scavenging ROS and inhibition of JAK-2/STAT-3 inflammatory pathway

AA Shati - Journal of Taibah University for Science, 2017 - Elsevier
Recent evidence has shown that reactive oxygen species (ROS), inflammation and the
activation of JAK/STAT signalling are major pathways in the induction and progression of …

PPAR gamma agonist, pioglitazone, rescues liver damage induced by renal ischemia/reperfusion injury

S Elshazly, E Soliman - Toxicology and applied pharmacology, 2019 - Elsevier
Remote organ damage is the major cause of death in patients with acute kidney injury (AKI)
due to renal ischemia reperfusion (IR). Liver is one of the vital organs which are profoundly …

Oxypurinol protects renal ischemia/reperfusion injury via heme oxygenase-1 induction

HB Kang, CK Lim, J Kim, SJ Han - Frontiers in Medicine, 2023 - frontiersin.org
Renal ischemia/reperfusion (I/R) injury is a major cause of acute kidney injury (AKI) by
increasing oxidative stress, inflammatory responses, and tubular cell death. Oxypurinol, an …

Antioxidant U74389G improves glycerol-induced acute renal failure without affecting PPARγ gene

Z Yousefipour, H Hercule, AO Oyekan, MA Newaz - Renal failure, 2007 - Taylor & Francis
Oxygen metabolites play an important role in the pathogenesis of myoglobinuric acute renal
failure (ARF). Previously, we have reported a down regulation of peroxisome proliferator …

Pioglitazone Ameliorates Renal Ischemia-Reperfusion Injury via Inhibition of NF-κB Activation and Inflammation in Rats

G Zou, Z Zhou, X Xi, R Huang, H Hu - Frontiers in Physiology, 2021 - frontiersin.org
Renal ischemia-reperfusion injury (IRI) is considered as a major cause of acute kidney
injury. In this study, we investigated the role of the NF-κB signaling pathway and …

Protective effects of pioglitazone in renal ischemia–reperfusion injury (RIRI): focus on oxidative stress and inflammation

M Golmohammadi, MS Ivraghi, EK Hasan… - Clinical and …, 2024 - Springer
Background Renal ischemia-reperfusion injury (RIRI) is a critical phenomenon that
compromises renal function and is the most serious health concern related to acute kidney …

[HTML][HTML] Pentoxifylline treatment alleviates kidney ischemia/reperfusion injury: Novel involvement of galectin-3 and ASK-1/JNK & ERK1/2/NF-κB/HMGB-1 trajectories

HM El-Sadek, MY Al-Shorbagy, MM Awny… - Journal of …, 2021 - Elsevier
Despite the documented renoprotective effect of pentoxifylline (PTX), a non-selective
phosphodiesterase-4 inhibitor, the studies appraised only its anti-inflammatory/-oxidant …

Pantoprazole attenuates MAPK (ERK1/2, JNK, p38)–NF-κB and apoptosis signaling pathways after renal ischemia/reperfusion injury in rats

MA Fawzy, SA Maher, SM Bakkar… - International Journal of …, 2021 - mdpi.com
Ischemia/reperfusion injury (IRI) in the kidney is the most common cause of acute renal
dysfunction through different cell damage mechanisms. This study aimed to investigate, on …

Pioglitazone ameliorates ischemia/reperfusion-induced acute kidney injury via oxidative stress attenuation and NLRP3 inflammasome

Z Ye, J Zhang, Z Xu, Z Li, G Huang, B Tong, P Xia… - Human Cell, 2024 - Springer
Acute kidney injury (AKI) induced by renal ischemia/reperfusion injury (IRI) is a severe
clinical condition. ROS accumulation, antioxidant pathways deficiency, and inflammation are …